NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.

Volume: 19, Issue: 11, Pages: 1218 - 1230
Published: Nov 1, 2021
Abstract
In the last decade, a better understanding of the molecular pathogenesis of B-cell non-Hodgkin lymphomas has resulted in the development of novel targeted therapies, such as small molecule inhibitors of select kinases in the B-cell receptor pathway, antibody-drug conjugates, and small molecules that target a variety of proteins (eg, CD-19, EZH2, and XPO-1-mediated nuclear export). Anti-CD19 CAR T-cell therapy, first approved for...
Paper Details
Title
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.
Published Date
Nov 1, 2021
Volume
19
Issue
11
Pages
1218 - 1230
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.